4//SEC Filing
QLT INC/BC 4
Accession 0001104659-16-160108
CIK 0000827809operating
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:05 PM ET
Size
6.3 KB
Accession
0001104659-16-160108
Insider Transaction Report
Form 4
QLT INC/BCNVLN
Chan Barbara Y
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2016-11-29+26,665→ 26,665 totalExercise: $1.55→ Common Shares (26,665 underlying)
Footnotes (2)
- [F1]25% of the common shares underlying this stock option award will vest on July 1, 2017. The remaining 75% of the common shares underlying this stock option award will vest thereafter in equal monthly installments through July 1, 2020, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or any of its subsidiaries.
- [F2]Pursuant to the Agreement and Plan of Merger, dated as of June 14, 2016, by and among the Issuer, Aegerion Pharmaceuticals, Inc. ("Aegerion") and Isotope Acquisition Corp. ("Isotope"), pursuant to which Isotope was merged with and into Aegerion, effective on November 29, 2016, the option to purchase common shares of the Issuer was received in exchange for an option to purchase 26,000 shares of Aegerion common stock.
Documents
Issuer
QLT INC/BC
CIK 0000827809
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000827809
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:05 PM ET
- Size
- 6.3 KB